Publisher: DataM Intelligence 4Market Research LLP
Category: Rheumatology/Arthritis
Category: Rheumatology/Arthritis
Rheumatology/Arthritis market research reports by DataM Intelligence 4Market Research LLP
(2 reports matching your criteria)
-
Global Adalimumab Market - 2022-2029
Global Adalimumab Market - 2022-2029 Market Overview Adalimumab market was valued at USD 3829.40 million in 2021. It is forecasted to reach USD YY million by 2029, growing at a CAGR of 5.2% during the forecast period (2022-2029). Adalimumab is approved under the brand name Humira for the treatment o ... Read More
-
Global Non-oncology Biopharmaceuticals Market - 2021-2028
Global Non-oncology Biopharmaceuticals Market - 2021-2028 Market Overview The global non-oncology biopharmaceuticals market size was worth US$ XX million in 2020 and is estimated to reach US$ XX million by 2028, growing at a CAGR of XX % during the forecast period (2021-2028). Biopharmaceuticals are ... Read More
Research Assistance
